Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.36 |
| ▸ | FADS1 | O60427 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL827237 | 0.80 | MAOA (0.50) | CYP1A2CYP2A6MAOAMAOBFTO | |
| SCHEMBL30200096 | 0.75 | CYP2A6 (0.37) | CYP1A2CYP2A6MAOAMAOBFTO | |
| Chromone SCHEMBL30876963 | 0.69 | MAOA (0.70) | MAOAMAOBFTOLMNA | |
| Chromone SCHEMBL31290986 | 0.65 | MAOA (0.64) | MAOAMAOBFTOLMNA | |
| SCHEMBL1256888 | 0.65 | AHR (0.41) | CYP2A6MAOAMAOBFTOFADS1 | |
| SCHEMBL28143837 | 0.64 | MAOA (0.47) | CYP1A2CYP2A6MAOAMAOBFTO | |
| SCHEMBL15019264 | 0.64 | MAOA (0.33) | MAOAMAOBFTOFADS1 | |
| SCHEMBL8799124 | 0.62 | MAOA (0.40) | CYP1A2CYP2A6MAOAMAOBFTO | |
| Benzofuran SCHEMBL30390756 | 0.62 | — | — | |
| SCHEMBL17843510 | 0.61 | CYP1A2 (0.39) | CYP1A2CYP2A6LMNANR4A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023000834-A1 | BENZIMIDAZOLE OR AZABENZIMIDAZOLE-6-CARBOXYLIC ACID COMPOUND AND USE THEREOF | 广州必贝特医药股份有限公司 | 2023-01-26 | — | — | WO | disclosed |